Entrada Therapeutics saw the highest growth of 0.85% in patent filings and no patents were granted in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.85% and no change in grants. GlobalData’s DataBook provides a comprehensive analysis of Entrada Therapeutics’s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Entrada Therapeutics has been focused on protecting inventions in Israel(IL) with two publications in Q2 2024
The Israel(IL) Patent Office dominates the patent filings with nearly 29% of filings. The Israel(IL), World Intellectual Property Organization(WIPO), Australia(AU), and Dominican Republic(DO) patent Office are among the top ten patent offices where Entrada Therapeutics is filings its patents..
Roche could be the strongest competitor for Entrada Therapeutics
In terms of grant share, Entrada Therapeutics stands in sixth position among its competitors. Entrada Therapeutics and Roche secured the top positions according to recent patent publication data.
Patents related to rare diseases lead Entrada Therapeutics's portfolio
Entrada Therapeutics has the highest number of patents in rare diseases. For rare diseases, nearly 100% of patents were filed and 100% of patents were granted in Q2 2024.
Duchenne muscular dystrophy related patents lead Entrada Therapeutics portfolio followed by ataxia, and huntington disease
Entrada Therapeutics has highest number of patents in duchenne muscular dystrophy followed by ataxia, huntington disease, spinocerebellar ataxia (sca), and myotonic dystrophy.
For comprehensive analysis of Entrada Therapeutics's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
